Colgate-Palmolive Company $CL Stock Holdings Raised by Exchange Traded Concepts LLC

Exchange Traded Concepts LLC grew its stake in Colgate-Palmolive Company (NYSE:CL) by 15.0% during the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 400,137 shares of the company’s stock after purchasing an additional 52,261 shares during the quarter. Exchange Traded Concepts LLC’s holdings in Colgate-Palmolive were worth $31,987,000 as of its most recent filing with the SEC.

Other hedge funds have also bought and sold shares of the company. Somerset Trust Co lifted its holdings in Colgate-Palmolive by 1.3% during the 3rd quarter. Somerset Trust Co now owns 26,921 shares of the company’s stock worth $2,152,000 after buying an additional 344 shares during the last quarter. S.E.E.D. Planning Group LLC raised its position in shares of Colgate-Palmolive by 39.1% during the 3rd quarter. S.E.E.D. Planning Group LLC now owns 58,408 shares of the company’s stock valued at $4,669,000 after acquiring an additional 16,424 shares in the last quarter. Bridge Creek Capital Management LLC lifted its stake in Colgate-Palmolive by 0.4% during the third quarter. Bridge Creek Capital Management LLC now owns 58,479 shares of the company’s stock worth $4,675,000 after purchasing an additional 219 shares during the last quarter. Legacy Wealth Asset Management LLC increased its stake in Colgate-Palmolive by 239.7% during the third quarter. Legacy Wealth Asset Management LLC now owns 23,612 shares of the company’s stock valued at $1,888,000 after purchasing an additional 16,662 shares during the last quarter. Finally, Brighton Jones LLC raised its holdings in shares of Colgate-Palmolive by 2.6% during the third quarter. Brighton Jones LLC now owns 11,262 shares of the company’s stock worth $900,000 after purchasing an additional 290 shares during the period. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Colgate-Palmolive Stock Up 1.0%

Shares of Colgate-Palmolive stock opened at $78.50 on Monday. The company has a quick ratio of 0.60, a current ratio of 0.93 and a debt-to-equity ratio of 5.90. The stock has a 50 day moving average price of $78.32 and a two-hundred day moving average price of $83.02. The stock has a market capitalization of $63.28 billion, a P/E ratio of 21.99, a PEG ratio of 5.58 and a beta of 0.30. Colgate-Palmolive Company has a 12-month low of $74.54 and a 12-month high of $100.18.

Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, October 31st. The company reported $0.91 earnings per share for the quarter, beating the consensus estimate of $0.89 by $0.02. Colgate-Palmolive had a return on equity of 333.39% and a net margin of 14.47%.The firm had revenue of $5.13 billion during the quarter, compared to the consensus estimate of $5.17 billion. During the same quarter in the prior year, the company earned $0.91 EPS. The firm’s revenue for the quarter was up 1.9% compared to the same quarter last year. Equities analysts expect that Colgate-Palmolive Company will post 3.75 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Stockholders of record on Wednesday, January 21st will be issued a dividend of $0.52 per share. This represents a $2.08 annualized dividend and a dividend yield of 2.6%. The ex-dividend date is Wednesday, January 21st. Colgate-Palmolive’s dividend payout ratio is presently 58.26%.

Wall Street Analysts Forecast Growth

CL has been the subject of several research reports. UBS Group decreased their price target on shares of Colgate-Palmolive from $92.00 to $90.00 and set a “buy” rating for the company in a report on Monday, November 3rd. Citigroup reduced their price target on shares of Colgate-Palmolive from $105.00 to $95.00 and set a “buy” rating for the company in a report on Monday, November 3rd. Morgan Stanley decreased their price objective on Colgate-Palmolive from $96.00 to $87.00 and set an “overweight” rating for the company in a report on Monday, November 3rd. Raymond James Financial lowered their target price on shares of Colgate-Palmolive from $105.00 to $95.00 and set an “outperform” rating on the stock in a research note on Monday, October 20th. Finally, Wells Fargo & Company lowered their price target on Colgate-Palmolive from $80.00 to $77.00 and set an “underweight” rating on the stock in a research report on Monday, November 3rd. Ten research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $88.81.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.